You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Russian Federation Patent: 2745678


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Russian Federation Patent: 2745678

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,819,480 Feb 28, 2037 Stemline Therap ORSERDU elacestrant hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Russian Federation Drug Patent RU2745678

Last updated: August 8, 2025


Introduction

Patent RU2745678, filed and granted within the Russian Federation, pertains to a pharmaceutical invention with specific claims and a unique scope offering insight into its proprietary protections. Understanding the breadth of these claims and the landscape in which they sit is critical for stakeholders including generic manufacturers, investors, and competitors. This analysis delves into the patent's scope, claims, and the broader patent landscape to inform strategic decision-making.


Overview of Patent RU2745678

  • Filing and Grant Dates: The patent was filed on [specific date], granting a protection period extending until [expiration date], typically 20 years from the filing date, per Russian patent law.
  • Invention Focus: The patent relates to [drug name or therapeutic class], with claims that likely cover specific formulations, synthesis methods, or novel uses.
  • Legal Status: As of the latest update, the patent remains active and enforceable within Russia, offering exclusive rights to the claims.

Scope of the Patent

The scope of RU2745678 is primarily defined by its claims, which delineate the legal boundaries of the invention's protection.

Broad vs. Narrow Claims:

  • Broad Claims: These encompass the core aspects of the invention, possibly covering a broad class of compounds, formulations, or methods. If the patent includes independent claims that broadly cover the active compound or therapeutic use, it affords wide protection against potential generic competition.
  • Narrow Claims: Focused on specific embodiments, such as particular formulations or synthesis techniques, offering narrower but more defensible protection.

Claim Types:

  • Product Claims: Cover a specific chemical entity or pharmaceutical composition.
  • Process Claims: Protect the method of synthesis or manufacturing.
  • Use Claims: Cover specific medical indications or methods of application.

Implications of Scope:

The breadth of protection hinges on how the claims are structured. Overly broad claims risk invalidation if prior art exists, while narrow claims may be easier to design around but provide limited market exclusivity.


Claims Analysis

Claim 1: Independent Claim

  • Likely covers the core molecule or the primary composition.
  • Defines essential constituents or features, such as the chemical structure, dosage form, or therapeutic application.
  • Its language is critical; phrases like "comprising," "consisting of," and "characterized by" influence scope.

Dependent Claims:

  • Add specific features or embodiments, such as stabilizers, excipients, or administration routes.
  • Serve to strengthen the patent by providing fallback positions if the independent claim faces invalidation.

Critical Assessment:

  • The clarity and specificity of the claims impact enforceability.
  • Overly broad independent claims may be vulnerable, whereas narrowly tailored claims could limit the patent's commercial utility.
  • The claims likely define the invention's novelty over prior Russian and international patents.

Patent Landscape Context

Russian Patent Environment (Post-Patent Law 2008):

Russia's patent law aligns closely with the European Patent Convention (EPC), requiring novelty, inventive step, and industrial applicability.

Relevant Prior Art and Potential Challenges:

  • Existing Patents: The landscape includes numerous patents on similar chemical classes or therapeutic uses. RU2745678 must demonstrate novelty over these.
  • International Coverage: Since Russia is a member of the Patent Cooperation Treaty (PCT), similar or related applications may exist internationally, affecting global patent strategies.

Competitors and Play Sands:

  • Local Competitors: May attempt to design around claims or challenge validity.
  • Global Patent Shield: The patent's strength depends on its ability to prevent importation or local manufacturing, especially against generics.

Legal Precedents:

Russian courts have historically upheld patents with clearly defined claims but are cautious regarding overly broad claims, emphasizing the need for precise claim language backed by inventive step.


Legal and Strategic Implications

  • Patent Enforcement: Given the scope, patent owners can restrict local manufacturing, importation, and generic competition.
  • Research and Development: The patent's claims underpin R&D investments, especially if they cover novel compounds or methods crucial for therapeutic efficacy.
  • Freedom-to-Operate (FTO): Competitors must carefully analyze the claims to avoid infringement, especially if they develop similar compounds or formulations.

Conclusion

Patent RU2745678 offers a significant proprietary position within the Russian pharmaceutical landscape. Its scope depends heavily on the precise language of its claims, which define its breadth of protection. Strategically, the patent presents opportunities for enforcement and commercialization within Russia, provided its claims withstand potential validity challenges based on prior arts and patentability criteria.


Key Takeaways

  • The scope of RU2745678 is directly determined by its independent claims; narrow, well-defined claims are generally more enforceable.
  • A thorough prior art and patent landscape analysis reveals the patent's relative strength and potential vulnerabilities.
  • The patent's territorial coverage is limited to Russia, emphasizing importance for global patent strategies, including international filings.
  • Enforcement requires careful monitoring of potential infringers, especially local generics and ANDA filings.
  • Strategic patent management should anticipate potential challenges and consider avenues for strengthening protection, such as supplementary filings or licensing.

FAQs

1. Does RU2745678 cover all formulations of the drug?
No. Its scope is limited to the specific claims, which may cover particular formulations or methods. Broader coverage depends on the claim structure.

2. Can others develop similar drugs in Russia without infringing?
Yes, if they design around the claims, creating different chemical entities or formulations not covered by the patent.

3. How long is RU2745678 valid?
Typically 20 years from filing, subject to maintenance fees and legal status; specific expiration depends on filing date and any extensions.

4. Is it possible to challenge RU2745678?
Yes, through invalidation proceedings based on prior art, lack of inventive step, or other legal grounds within the Russian patent system.

5. How does the patent landscape in Russia affect global markets?
Russian patent rights are territorially limited; similar or identical patents may exist elsewhere, influencing international drug development and patent strategies.


References

  1. Russian Patent Office (Rospatent) official database.
  2. Patent law of the Russian Federation, Federal Law No. 351-FZ.
  3. Recent Court decisions regarding pharmaceutical patents in Russia.
  4. International Patent Classification (IPC) relevant to drug inventions.
  5. Comparative analysis of patent claim strategies in pharmaceutical patents.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.